Currently available interviews:
Electrophysiology Research
Previous Heart Rhythm Society Research Fellowships awardees who participated in the Society's 2010 Research Forum are interviewed on the impact their award has had on themselves, the EP field, and patient care; discuss research funding in today's environment and the importance of research funding. Watch interviews now »
Innovations in Ablation
Ania C. Garlitski, MD Tufts-New England Medical Center, Boston, MA interviews the following physicians on advances in tools and techniques related to cardiac ablation procedures:
- Novel Tools for AF Ablation: An Update — Moussa M. Mansour, MD, Massachusetts General Hospital Heart Center: Watch interview now (5:10) »
- Emerging Technologies in AF—Novel Approaches to SVT Ablation — Suneet Mittal, MD, FHRS, St. Luke's-Roosevelt Hospital Center, New York, NY: Watch interview now (5:05) »
Return to top
Late-Breaking Clinical Trials
Interview conducted by Sonja Olson, then with DTA2 Consulting, Minneapolis-St. Paul
- Programming Strategies Associated With Shock Reduction In 88,804 Implantable Defibrillator Patients — Bruce L. Wilkoff, MD, FHRS, CCDS, Cleveland Clinic, Cleveland, OH the study proving that strategic programming of implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-D) reduces shocks between 17 and 28 percent. Watch interview now (8:06) »
Interviews conducted by Robert C. Kowal, MD, Ph.D. Heart Place, The Baylor University Medical Center:
- Device Therapy in the Treatment of Heart Failure — David S. Cannom, MD, FHRS, Los Angeles Cardiology Associates is interviewed about results from the Multicenter Automatic Defibrillator Implantation Trial-CRT (MADIT-CRT). Watch interview now (6:06) »
- Use of Implantable Loop Recorders Leads to Specific Diagnosis and Treatment of "Unexplained Syncope" Patients in Clinical Practice — Results from an International Multi-Center Study — Nils G. Edvardsson, MD, Ph.D., Sahlgrenska University Hospital discusses PICTURE, which showed that the diagnoses provided by the implantable loop recorder led to specific therapy. Watch interview now (4:46) »
Interviews conducted by Kenneth A. Ellenbogen, MD, FHRS, Virginia Commonwealth University Medical Center:
- New Antiarrhythmics for AF: Trial Data — James A. Reiffel, MD, FHRS, Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons discusses the trial data on the safety, efficacy and management of new antiarrhythmic drugs. Watch interview now (10:46) »
- Clinical Efficacy and Safety of Vernakalant Compared with Amiodarone for Intravenous Conversion of Recent Onset Atrial Fibrillation — A. John Camm, MD, FHRS, St. George's Hospital Medical School, London, England, discusses the study that compared the efficacy and safety of vernakalant with amiodarone for conversion of recent onset AF to sinus rhythm. Watch interview now (6:31) »
- Omega-3 Polyunsaturated Fatty Acids for Prevention of Postoperative AF — Chirag Sandesara, MD, Virginia Cardiovascular Associates is interviewed about the trial testing the hypothesis that purified omega-3 polyunsaturated fatty acids reduce AF after coronary artery bypass graft surgery. Watch interview now (5:12) »
- J-Rhythm II Study: A Randomized Comparison on Angiotensin Receptor Blocker vs Ca Antagonist for Paroxysmal AF with Hypertension — Takeshi Yamashita, MD, Ph.D., The Cardiovascular Institute, Tokyo, Japan, on the randomized comparative evaluation of an angiotensin II type 1 blocker (candesartan) and a Ca blocker (amlodipine) as an antiarrhythmic therapy for the treatment of frequent paroxysmal AF associated with hypertension. Watch interview now (5:30) »
- Steroid Injection for Reduction of Severe Arrhythmias Following AF Ablation — Daniel P. Melby, MD, University of Minnesota discusses the prospective, double blind, placebo controlled randomized study on the effect of a single post-procedure dose of IV methlyprednisolone on severe arrhythmias during the 6 weeks following ablation. Watch interview now (5:48) »
- North American STOP-AF Trial: Outcomes Assessments — Jeremy N. Ruskin, MD, Massachusetts General Hospital, Boston, MA discusses the STOP-AF Pivotal Trial where pulmonary vein isolation using cryoablation was performed in patients with symptomatic paroxysmal atrial fibrillation (PAF) and compared to subjects treated with anti-arrhythmic drug (AAD) therapy. Watch interview now (10:57) »
Return to top
Leaders in Quality
Ariana Del Negro, the Society's "Quality Blogger" at Heart Rhythm 2010 (view her EP Insights posts on the quality and outcomes discussions), interviews two of the Society's past presidents:
- Programming Devices to Optimize Patient Outcomes — David L. Hayes, MD, FHRS, Mayo Clinic, Rochester, MN. Watch Hayes interview now (5:49) »
- Medical Issues after Ablation of Atrial Fibrillation and Flutter — Richard L. Page, MD, FHRS, Chair, Department of Medicine, University of Wisconsin, Madison, WI. Watch Page interview now (6:05) »
Return to top
VT/VF/Heart Failure Summit
The VT/VF/Heart Failure Summit at Heart Rhythm 2010 took place on May 12, 2010. Summit faculty members William J. Groh, MD; Alfred E. Buxton, MD; Christine M. Albert, MD and Lynne W. Stevenson, MD are interviewed by E. Kevin Heist, MD, Ph.D. Learn more and watch interviews »
Return to top
Women's Leadership Initiative
Anne M. Gillis, MD, FHRS, Jodie L. Hurwitz, MD, FHRS, Andrea M. Russo, MD, FHRS, Anne B. Curtis, MD, FHRS and Ania C. Garlitski, MD, discuss the keys to success as a female EP, the importance of a mentor and the Women's Leadership Initiative and offer suggestions for other women pursuing a career in EP. Learn more and watch interviews »
Return to top
Emerging Electrophysiologists: My Story
"My Story" sessions feature distringuished clinicians in the EP field sharing personal strategies for success with those wishing to gain an advantage in today's dynamic and complex health care environment. Viewers are given an opportunity to expand upon personal knowledge and skills by exploring the business of medicine through the eyes of seasoned peers to ensure future success. Learn more »
Return to top
